Author:
Gould Ian M.,David Michael Z.,Esposito Silvano,Garau Javier,Lina Gerard,Mazzei Teresita,Peters Georg
Funder
National Institutes of Health
Funds for Health of Spain (FIS)
French Government
FINOVI Foundation
Pfizer
Novartis
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference101 articles.
1. European Centre for Disease Prevention and Control/European Medicines Agency (ECDC/EMEA). Technical report. The bacterial challenge: time to react. Stockholm, Sweden: ECDC/EMEA; 2009. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf [accessed 21.07.11].
2. European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report on communicable diseases in Europe 2009. Stockholm, Sweden: ECDC; 2010. http://www.ecdc.europa.eu/en/publications/Publications/0910_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf [accessed 14.06.11].
3. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections;de Kraker;Antimicrob Agents Chemother,2011
4. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis;Cosgrove;Clin Infect Dis,2003
5. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus;Shurland;Infect Control Hosp Epidemiol,2007